Ayman Saad
@aymansaadosu
BMT/Cell Therapy. KFSHRC (Riyadh, Saudi Arabia). Ex-Professor, Ohio State University
ID: 55935838
11-07-2009 21:32:25
435 Tweet
1,1K Followers
889 Following
Uncommon Entities, Uncommon Challenges: A Review of Rare Plasma Cell Disorders ✔️By Myeloma team مستشفى الملك فيصل التخصصي ومركز الأبحاث mdpi.com/2038-8330/17/4…
Congratulations to Anthony Daniyan & team from Memorial Sloan Kettering Cancer Center on publication of the initial data from AML patients treated with IL-18 secreting CD371 CAR T cells @MSK. ashpublications.org/blood/article-… 3 / 5 patients experienced MRD-negative morphologic leukemia free state.
Interesting and great work Ruah Alyamany | روى اليماني & Ahmed AlNughmush 👌 I suspect if ATG is removed from the RIC, the latter may even supersede MAC!
thank you Dr. Dispenzieri for wonderful talk on MRD in multiple myeloma in SOHO Saudi Arabia. Angela Dispenzieri Mayo Clinic Society of Hematologic Oncology (SOHO) مستشفى الملك فيصل التخصصي ومركز الأبحاث
Thank you Dr. Al-Ola Abdallah for the great talk on CAR T at SOHO Saudi Arabia. Al-Ola A Abdallah MD (USMIRC) مستشفى الملك فيصل التخصصي ومركز الأبحاث Society of Hematologic Oncology (SOHO) University of Kansas
Fantastic talk by Dr. Hans Hasselbalch of University of Copenhagen at SOHO Saudi Arabia Society of Hematologic Oncology (SOHO) مستشفى الملك فيصل التخصصي ومركز الأبحاث